Vital Therapies Inc (VTL) on Focus After Forming Bearish Double Bottom Chart Pattern

September 17, 2017 - By Hazel Jackson

Investors sentiment increased to 1.56 in 2016 Q4. Its up 0.75, from 0.81 in 2016Q3. It improved, as 4 investors sold Vital Therapies Inc shares while 12 reduced holdings. 9 funds opened positions while 16 raised stakes. 8.03 million shares or 1.33% more from 7.92 million shares in 2016Q3 were reported.
Natl Bank Of America Corporation De holds 0% in Vital Therapies Inc (NASDAQ:VTL) or 7,734 shares. Ironwood Ltd Llc stated it has 0% of its portfolio in Vital Therapies Inc (NASDAQ:VTL). Meeder Asset Incorporated invested in 0% or 2,231 shares. Jpmorgan Chase And, a New York-based fund reported 32,601 shares. 52,500 are owned by Sei Invests Co. Blair William & Communication Il has 59,500 shares for 0% of their portfolio. Fmr Ltd Llc owns 1.46M shares. Fifth Third Savings Bank holds 3,000 shares or 0% of its portfolio. D E Shaw & accumulated 66,231 shares. Ny State Common Retirement Fund accumulated 15,300 shares. Blackrock Invest Mgmt Ltd Liability Co holds 0% or 87,852 shares in its portfolio. State Street holds 0% or 328,091 shares in its portfolio. Art Limited Liability has 15,200 shares. Nationwide Fund Advsr accumulated 0% or 14,423 shares. Voya Investment Mgmt Lc reported 0% stake.

Since March 27, 2017, it had 9 insider purchases, and 0 selling transactions for $15.32 million activity. 3,900 shares valued at $12,182 were bought by Nash Duane on Thursday, June 8. DUNN JOHN MICHAEL bought 2,500 shares worth $7,724. $15.00M worth of stock was bought by Satter Muneer A on Monday, March 27. Winters Terence E. bought 10,000 shares worth $30,981. BIENAIME JEAN JACQUES bought $48,069 worth of Vital Therapies Inc (NASDAQ:VTL) on Tuesday, June 13.

The chart of Vital Therapies Inc (VTL) shows a double bottom with $4.37 target or 3.00 % below today’s $4.50 share price. The 9 months chart pattern indicates high risk for the $189.93 million company. It was reported on Sep, 17 by Finviz.com. If the $4.37 price target is reached, the company will be worth $5.70M less. Double bottoms are rare but powerful chart patterns.

The stock increased 5.88% or $0.25 on September 15, reaching $4.5. About 587,555 shares traded or 217.78% up from the average. Vital Therapies Inc (NASDAQ:VTL) has declined 61.75% since September 17, 2016 and is downtrending. It has underperformed by 78.45% the S&P500.

Wall Street await Vital Therapies Inc (NASDAQ:VTL) to release earnings on November, 2. Analysts forecast EPS of $-0.30, up exactly $0.02 or 6.25 % from 2014’s $-0.32 EPS. After posting $-0.29 EPS for the previous quarter, Vital Therapies Inc’s analysts now forecast 3.45 % negative EPS growth.

Vital Therapies Inc (NASDAQ:VTL) Ratings Coverage

Among 7 analysts covering Vital Therapies Inc (NASDAQ:VTL), 3 have Buy rating, 0 Sell and 4 Hold. Therefore 43% are positive. Vital Therapies Inc had 11 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was downgraded by Suntrust Robinson to “Neutral” on Tuesday, September 29. William Blair downgraded the shares of VTL in report on Monday, August 24 to “Outperform” rating. The rating was downgraded by SunTrust on Tuesday, September 29 to “Neutral”. Suntrust Robinson downgraded Vital Therapies Inc (NASDAQ:VTL) on Monday, August 24 to “Neutral” rating. Credit Suisse downgraded the shares of VTL in report on Monday, August 24 to “Neutral” rating. BTIG Research downgraded Vital Therapies Inc (NASDAQ:VTL) on Monday, October 26 to “Neutral” rating. The firm earned “Buy” rating on Monday, August 24 by Canaccord Genuity. The rating was initiated by BTIG Research on Friday, August 7 with “Buy”. The firm earned “Outperform” rating on Monday, August 10 by Credit Suisse. The stock of Vital Therapies Inc (NASDAQ:VTL) earned “Buy” rating by SunTrust on Monday, August 24.

More notable recent Vital Therapies Inc (NASDAQ:VTL) news were published by: Seekingalpha.com which released: “Vital Therapies’ (VTL) CEO Terry Winters on Q2 2017 Results – Earnings Call …” on August 05, 2017, also Globenewswire.com with their article: “Vital Therapies Announces Appointment of Former Receptos President and CEO …” published on August 15, 2016, Globenewswire.com published: “Vital Therapies Provides Corporate Update” on January 09, 2017. More interesting news about Vital Therapies Inc (NASDAQ:VTL) were released by: Globenewswire.com and their article: “Vital Therapies Announces Second Quarter 2017 Financial Results” published on August 03, 2017 as well as Globenewswire.com‘s news article titled: “Vital Therapies Announces Recent and Upcoming Scientific Presentations and …” with publication date: September 11, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: